These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31278482)

  • 21. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens.
    Mayser P; Gross A
    Acta Derm Venereol; 2000; 80(5):357-61. PubMed ID: 11200834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malassezia furfur induces the expression of beta-defensin-2 in human keratinocytes in a protein kinase C-dependent manner.
    Donnarumma G; Paoletti I; Buommino E; Orlando M; Tufano MA; Baroni A
    Arch Dermatol Res; 2004 Apr; 295(11):474-81. PubMed ID: 14963722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antifungal activity of a coal tar gel on Malassezia furfur in vitro.
    Nenoff P; Haustein UF; Fiedler A
    Dermatology; 1995; 191(4):311-4. PubMed ID: 8573928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes.
    Balato A; Paoletti I; De Gregorio V; Cantelli M; Ayala F; Donnarumma G
    Mycoses; 2014 Mar; 57(3):176-83. PubMed ID: 24512536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malassezia species in patients with seborrheic dermatitis and atopic dermatitis].
    Tajima M
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(3):163-7. PubMed ID: 16094289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
    Ashbee HR; Ingham E; Holland KT; Cunliffe WJ
    Exp Dermatol; 1994 Jun; 3(3):106-12. PubMed ID: 7952921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography.
    Dall'Oglio F; Tedeschi A; Guardabasso V; Micali G
    J Clin Aesthet Dermatol; 2015 Sep; 8(9):33-8. PubMed ID: 26430489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.
    Youn HJ; Kim SY; Park M; Jung WH; Lee YW; Choe YB; Ahn KJ
    Ann Dermatol; 2016 Dec; 28(6):733-739. PubMed ID: 27904273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of antifungal agents in the treatment of seborrheic dermatitis.
    Gupta AK; Nicol K; Batra R
    Am J Clin Dermatol; 2004; 5(6):417-22. PubMed ID: 15663338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with a T helper 2-like peripheral blood mononuclear cells response.
    Johansson C; Eshaghi H; Linder MT; Jakobson E; Scheynius A
    J Invest Dermatol; 2002 Jun; 118(6):1044-51. PubMed ID: 12060401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult seborrheic dermatitis: a status report on practical topical management.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2011 May; 4(5):32-8. PubMed ID: 21607192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrheic dermatitis.
    Silva V; Fischman O; de Camargo ZP
    Mycopathologia; 1997; 139(2):79-85. PubMed ID: 9549101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous fungal microbiome:
    Kamamoto CSL; Nishikaku AS; Gompertz OF; Melo AS; Hassun KM; Bagatin E
    Dermatoendocrinol; 2017; 9(1):e1361573. PubMed ID: 29484095
    [No Abstract]   [Full Text] [Related]  

  • 34. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Masoudnia S; Raghifar R
    Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis.
    Georgescu SR; Mitran CI; Mitran MI; Amuzescu A; Matei C; Tampa M
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis.
    Piquero-Casals J; Hexsel D; Mir-Bonafé JF; Rozas-Muñoz E
    Dermatol Ther (Heidelb); 2019 Sep; 9(3):469-477. PubMed ID: 31396944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence of Malassezia furfur to human stratum corneum cells in vitro: a study of healthy individuals and patients with seborrhoeic dermatitis.
    Bergbrant IM; Faergemann J
    Mycoses; 1994; 37(5-6):217-9. PubMed ID: 7898520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label, single-center pilot study to determine the antifungal activity of a new nonsteroidal cream (Promiseb Topical Cream) after 7 days of use in healthy volunteers.
    Kircik L
    Clin Dermatol; 2009; 27(6 Suppl):S44-7. PubMed ID: 19878780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.